Work

EPH133 Real-World Effectiveness of Osimertinib in Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutation: Systematic Review and Meta-Analysis

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.03.1015

Authors: A. Almutairi, N. Alkhatib, M. Maghaireh, S. Halloush, O. Rashdan, A. Manasrah, I. Abraham, A. Almaaytah, H. Abumansour, M. Saleh, A. Khassawaneh

Institutions: Saudi Food and Drug Authority, Al-Zaytoonah University of Jordan, Applied Science Private University, Middle East University, Yarmouk University, University of Arizona, Jordan University of Science and Technology, University of Jordan

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4380151069

Cites:

Cited by:

Related to: 10